BGI Co-Win

Hemu Gene is a biotechnology company specializing in gene therapy technology aimed at treating hemoglobin diseases. It possesses independent research and development capabilities and a robust quality management system. The company utilizes two primary gene editing platforms, lentivirus and CRISPR/Cas, to advance its studies on gene therapy vectors and genetic engineering technology. Additionally, Hemu Gene has established hematopoietic stem gene therapy production lines and is actively pursuing international clinical collaborations and registration efforts. Its focus extends to the research and development of cell technology, medical research, and human genetic diagnosis and treatment, enhancing the understanding and application of human gene technology.

Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops medicines for cancer treatment based on molecular biology. It offers Y-Body, a humanized monoclonal therapeutic antibody that is made from human B cell bank and bi-specific antibodies by antibody engineering technology. The company also provides tumor bio therapeutics. Wuhan YZY Biopharma Co., Ltd. was founded in 2010 and is based in Wuhan, China.

Realmind Biotech specializes in the development and manufacturing of in vitro diagnostic (IVD) devices aimed at enhancing medical assessments. The company's innovative product line includes a range of diagnostic equipment such as miniaturized chemiluminescence analyzers, fully automated chemiluminescence point-of-care testing (POCT) systems, and microdroplet chip POCT technologies. These devices are utilized for various applications, including tumor detection and hormone testing, enabling real-time diagnosis. Realmind Biotech also provides specialized reagents to support healthcare professionals and patients in their diagnostic needs. Through its comprehensive blueprint of advanced IVD platforms, the company aims to improve the accuracy and efficiency of medical assessments.

ToloBio develops molecular diagnostics solutions for pathogen detection, disease screening, and precision medicine.

Nanjing F&S Pharmatech Co., Ltd. is a pharmaceutical technology company established in 2015 and located in Nanjing, China. The company specializes in providing pharmaceutical intermediates and differentiated active pharmaceutical ingredients (APIs), along with contract manufacturing organization (CMO) services. F&S Pharmatech focuses on the research and development of advanced pharmaceutical chemicals and intermediates, including sacubitril and diphenyl piperidine methanol. By offering intellectual property solutions and environmentally friendly chemical technology, the company aims to support customers in the healthcare industry, particularly research and development centers and generic drug developers, in shortening development cycles and reducing product costs.

Cellnuo develops pharmaceutical products to help patients reduce the incidence of hypoglycemia and maintain healthier blood glucose levels, improving health outcomes for patients.